Health
New target for drug development could fill a major gap in depression treatment – News-Medical.net
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects.
THE IDEA
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression.
The research was led by Lisa Monteggia,…
Continue Reading